Filter by Topic
Advanced Cell Technology, Inc. (ACT) is a biotechnology company that uses stem cell technology to develop novel therapies in the field of regenerative medicine. Formed in 1994, ACT grew from a small agricultural cloning research facility located in Worcester, Massachusetts, into a multi-locational corporation involved in using both human embryonic stem cells (hESC) and human adult stem cells as well as animal cells for therapeutic innovations.
The Carnegie Institution of Washington's (CIW) Embryology Department was opened in 1914 and remains one of six departments in the CIW. The department quickly became, and remains, world renowned for its many embryonic development discoveries. In 1913 Franklin P. Mall, Professor of Anatomy at Johns Hopkins Medical School, applied for a Carnegie grant to support his research with human embryos. Mall had a collection of over 800 human embryo specimens and was at the point of wanting to do more than just collect.
From its founding in 1910 until it closed its doors in 1939, the Eugenics Record Office (ERO) at Cold Spring Harbor Laboratory in New York was the center of the American Eugenics Movement. Charles Davenport, a geneticist and biologist, founded the ERO, and served as its director until 1934. Under the direction of Davenport and his associate, superintendant Harry H. Laughlin, the influence of the ERO on science and public policy waxed during the early twentieth century until after World War II.